Short-term Outcomes after Very Low-Dose Intravitreous Bevacizumab for Retinopathy of Prematurity.
Wallace, DK; Kraker, RT; Freedman, SF; Crouch, ER; Bhatt, AR; Hartnett, ME; Yang, MB; Rogers, DL; Hutchinson, AK; VanderVeen, DK; et al.
JAMA Ophthalmology.
2020;
138:698-701.
Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria.
Yang, MB; Yu, Y; Ying, G; Duros, TB; Nguyen, A; Maguire, MG; Brightwell-Arnold, M; Shaffer, J; Blanco, M; Brown, T; et al.
JAMA Ophthalmology.
2020;
138:31-37.
Treatment of non–type 1 retinopathy of prematurity in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) study.
Liu, T; Tomlinson, LA; Ying, GS; Yang, MB; Binenbaum, G.
Journal of American Association for Pediatric Ophthalmology and Strabismus.
2019;
23:332.e1-332.e6.
Effects of Myo-inositol on Type 1 Retinopathy of Prematurity Among Preterm Infants < 28="" weeks'="" gestational="" age="" a="" randomized="" clinical="">.
Phelps, DL; Watterberg, KL; Nolen, TL; Cole, CA; Cotten, CM; Oh, W; Poindexter, BB; Zaterka-Baxter, KM; Das, A; Lacy, CB; et al.
Journal of the American Medical Association.
2018;
320:1649-1658.
Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients.
Rice, ML; Wong, B; Horn, PS; Yang, MB.
Journal of American Association for Pediatric Ophthalmology and Strabismus.
2018;
22:192-196.
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity A Phase 1 Dosing Study.
Wallace, DK; Kraker, RT; Freedman, SF; Crouch, ER; Hutchinson, AK; Bhatt, AR; Rogers, DL; Yang, MB; Haider, KM; VanderVeen, DK; et al.
JAMA Ophthalmology.
2017;
135:654-656.
Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.
VanderVeen, DK; Melia, M; Yang, MB; Hutchinson, AK; Wilson, LB; Lambert, SR.
Ophthalmology: Journal of The American Academy of Ophthalmology.
2017;
124:619-633.
Length of Day during Early Gestation as a Predictor of Risk for Severe Retinopathy of Prematurity.
Yang, MB; Rao, S; Copenhagen, DR; Lang, RA.
Ophthalmology: Journal of The American Academy of Ophthalmology.
2013;
120:2706-2713.
A direct and melanopsin-dependent fetal light response regulates mouse eye development.
Rao, S; Chun, C; Fan, J; Kofron, JM; Yang, MB; Hegde, RS; Ferrara, N; Copenhagen, DR; Lang, RA.
Nature.
2013;
494:243-246.
Race, gender, and clinical risk index for babies (CRIB) score as predictors of severe retinopathy of prematurity.
Yang, MB; Donovan, EF; Wagge, JR.
Journal of American Association for Pediatric Ophthalmology and Strabismus.
2006;
10:253-261.